Credit: Dr. Elizabeth Wellberg.

Elizabeth Wellberg, PhD profile page

Assistant Professor of Pathology

at University of Oklahoma Health Campus

Dr. Elizabeth Wellberg received her PhD in toxicology in 2009 from Texas A&M University, where she studied mammary gland biology and development. She completed postdoctoral training at the University of Colorado Anschutz Medical Campus, where she studied breast cancer metabolism and the effects of obesity on breast cancer risk and progression. She currently leads a lab at the University of Oklahoma Health Campus, focused on projects that investigate how weight gain and adipose tissue promote breast cancer progression and how breast cancer therapies impact metabolic function in cancer survivors.

Education

Texas A&M University

Got a Question for Elizabeth Wellberg, PhD?

Get in touch using the contact form linked here and we'll get back to you shortly.

Content Written By, Reviewed By, or Featuring Elizabeth Wellberg, PhD

Total: 1

A person stands on a digital scale, holding a GLP-1 drug dispensing injector.

Article

Could GLP-1s Prevent Cancer?

GLP-1 drugs may influence cancer risk by reversing obesity-related metabolic dysfunction and inflammation. Researchers are now working to separate weight-loss effects from potential direct actions on cancer and immune cells.